These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9341162)

  • 41. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts.
    Cotán D; Cordero MD; Garrido-Maraver J; Oropesa-Ávila M; Rodríguez-Hernández A; Gómez Izquierdo L; De la Mata M; De Miguel M; Lorite JB; Infante ER; Jackson S; Navas P; Sánchez-Alcázar JA
    FASEB J; 2011 Aug; 25(8):2669-87. PubMed ID: 21551238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNA(Leu(UUR)) mutation of mitochondrial DNA.
    Campos Y; Martin MA; Lorenzo G; Aparicio M; Cabello A; Arenas J
    Muscle Nerve; 1996 Feb; 19(2):187-90. PubMed ID: 8559168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial recurrence of atypical symptoms in an extended pedigree with the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).
    Dougherty FE; Ernst SG; Aprille JR
    J Pediatr; 1994 Nov; 125(5 Pt 1):758-61. PubMed ID: 7965431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic interventions against complex I deficiency in MELAS syndrome.
    Majamaa K; Rusanen H; Remes A; Hassinen IE
    Mol Cell Biochem; 1997 Sep; 174(1-2):291-6. PubMed ID: 9309702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA.
    Moraes CT; Ciacci F; Silvestri G; Shanske S; Sciacco M; Hirano M; Schon EA; Bonilla E; DiMauro S
    Neuromuscul Disord; 1993 Jan; 3(1):43-50. PubMed ID: 8392410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).
    Goto Y; Nonaka I; Horai S
    Biochim Biophys Acta; 1991 Oct; 1097(3):238-40. PubMed ID: 1932147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extra-pancreatic manifestations in diabetes secondary to mitochondrial DNA point mutation within the tRNALeu(UUR) gene.
    Vialettes B; Paquis-Fluckinger V; Silvestre-Aillaud P; Ben Dahan D; Pelissier JF; Etchary-Bouyx F; Raccah D; Gin H; Guillausseau PJ; Vanuxen D
    Diabetes Care; 1995 Jul; 18(7):1023-8. PubMed ID: 7555536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree.
    Dubeau F; De Stefano N; Zifkin BG; Arnold DL; Shoubridge EA
    Ann Neurol; 2000 Feb; 47(2):179-85. PubMed ID: 10665488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria.
    Karicheva OZ; Kolesnikova OA; Schirtz T; Vysokikh MY; Mager-Heckel AM; Lombès A; Boucheham A; Krasheninnikov IA; Martin RP; Entelis N; Tarassov I
    Nucleic Acids Res; 2011 Oct; 39(18):8173-86. PubMed ID: 21724600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel point mutation in the mitochondrial tRNA(Leu)(UUR) gene in a family with mitochondrial myopathy.
    Goto Y; Tojo M; Tohyama J; Horai S; Nonaka I
    Ann Neurol; 1992 Jun; 31(6):672-5. PubMed ID: 1514779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines.
    DiFrancesco JC; Cooper JM; Lam A; Hart PE; Tremolizzo L; Ferrarese C; Schapira AH
    Exp Neurol; 2008 Jul; 212(1):152-6. PubMed ID: 18455161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF).
    Seibel P; Degoul F; Bonne G; Romero N; François D; Paturneau-Jouas M; Ziegler F; Eymard B; Fardeau M; Marsac C
    J Neurol Sci; 1991 Oct; 105(2):217-24. PubMed ID: 1661776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease.
    Kirino Y; Yasukawa T; Ohta S; Akira S; Ishihara K; Watanabe K; Suzuki T
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15070-5. PubMed ID: 15477592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
    Desquiret-Dumas V; Gueguen N; Barth M; Chevrollier A; Hancock S; Wallace DC; Amati-Bonneau P; Henrion D; Bonneau D; Reynier P; Procaccio V
    Biochim Biophys Acta; 2012 Jun; 1822(6):1019-29. PubMed ID: 22306605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation.
    Park H; Davidson E; King MP
    Biochemistry; 2003 Feb; 42(4):958-64. PubMed ID: 12549915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High frequency of migraine-only patients negative for the 3243 A>G tRNALeu mtDNA mutation in two MELAS families.
    Cevoli S; Pallotti F; La Morgia C; Valentino ML; Pierangeli G; Cortelli P; Baruzzi A; Montagna P; Carelli V
    Cephalalgia; 2010 Aug; 30(8):919-27. PubMed ID: 20656703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes)].
    Goto Y
    Ryoikibetsu Shokogun Shirizu; 2001; (36):146-9. PubMed ID: 11596349
    [No Abstract]   [Full Text] [Related]  

  • 59. Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS).
    Kobayashi Y; Momoi MY; Tominaga K; Shimoizumi H; Nihei K; Yanagisawa M; Kagawa Y; Ohta S
    Am J Hum Genet; 1991 Sep; 49(3):590-9. PubMed ID: 1715668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel mutation in the mitochondrial 16S rRNA gene in a patient with MELAS syndrome, diabetes mellitus, hyperthyroidism and cardiomyopathy.
    Hsieh RH; Li JY; Pang CY; Wei YH
    J Biomed Sci; 2001; 8(4):328-35. PubMed ID: 11455195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.